Form4insider filings, from the source

Insider holders · CIK 0001371217

ReShape Lifesciences Inc. · RSLS

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Rajesh NihalaniChief Technology Officer978,845—978,845May 24, 2017 · 6:22 pm EDTForm 4
HealthCor Partners II, L.P.10% Owner174,472—174,472Jun 5, 2018 · 4:26 pm EDTForm 4
HealthCor Partners Fund II, L.P.10% Owner174,472—174,472Jun 5, 2018 · 4:26 pm EDTForm 4
Jeffrey C Lightcap10% Owner174,472—174,472Jun 5, 2018 · 4:26 pm EDTForm 4
HealthCor Partners Management GP, LLC10% Owner174,472—174,472Jun 5, 2018 · 4:26 pm EDTForm 4
HealthCor Partners Management LP10% Owner174,472—174,472Jun 5, 2018 · 4:26 pm EDTForm 4
HealthCor Partners GP, LLC10% Owner174,472—174,472Jun 5, 2018 · 4:26 pm EDTForm 4
Arthur Bruce Cohen10% Owner174,472—174,472Jun 5, 2018 · 4:26 pm EDTForm 4
Joseph Patrick Healey10% Owner174,472—174,472Jun 5, 2018 · 4:26 pm EDTForm 4
Mark B KnudsonDirector40,8673,83844,705May 6, 2016 · 5:12 pm EDTForm 4
Michael Y MashaalDirector—26,20026,200Dec 21, 2017 · 4:08 pm ESTForm 4
Cathy FriedmanDirector2,00011,80013,800May 8, 2015 · 4:57 pm EDTForm 4
Anthony P. JanszDirector—10,00010,000May 6, 2016 · 4:59 pm EDTForm 4
Dan W GladneyChairman, President and CEO1,925—1,925Apr 20, 2018 · 4:54 pm EDTForm 4
Katherine S. TwedenVP - Clinical and Regulatory1,053—1,053Mar 11, 2015 · 5:11 pm EDTForm 4
Deborah L. SchmalzVP, Clinical, Reg Aff. & Qual.1,000—1,000Nov 13, 2017 · 4:42 pm ESTForm 3
SABBY MANAGEMENT, LLC10% Owner—507507Feb 4, 2019 · 1:35 pm ESTForm 4
Peter M. DeLangeSVP, Ops & Bus Dev3912393Feb 10, 2017 · 4:41 pm ESTForm 4
Gregory S LeaCFO and CCO184—184Jun 28, 2016 · 5:11 pm EDTForm 4
Naqeeb A. AnsariVP, Int'l Sales & US Vet Hosp.143—143Oct 12, 2017 · 5:59 pm EDTForm 4
Bobby Ivan GriffinDirector52—52Feb 10, 2017 · 4:47 pm ESTForm 4
Nicholas TetiDirector10—10Feb 10, 2017 · 4:53 pm ESTForm 4
Jon T TremmelDirector2—2Feb 10, 2017 · 4:54 pm ESTForm 4
Amy L. ScottVP, Marketing & Patient Access0—0Nov 13, 2017 · 4:47 pm ESTForm 3
Robert C. HaggertyVP, U.S. Commercial Sales0—0Nov 13, 2017 · 4:34 pm ESTForm 3
Paul F. HickeySVP of Mktg & Reimb0—0Feb 10, 2017 · 4:49 pm ESTForm 4
Lori Courtney McDougalDirector0—0Feb 10, 2017 · 4:50 pm ESTForm 4
Scott A ShikoraEVP & Chief Medical Officer0—0Jun 28, 2016 · 5:10 pm EDTForm 4
Bradford C HancockChief Commercial Officer0—0May 14, 2015 · 4:48 pm EDTForm 3
Adrianus DondersSr VP of Research & Adv Dev0—0Mar 11, 2015 · 5:10 pm EDTForm 4
Arda Minocherhomjee Ph.D.Director0—0Aug 29, 2018 · 4:06 pm EDTForm 3
Scott P YoungstromCFO and SVP, Finance0—0Apr 20, 2018 · 5:01 pm EDTForm 4
Gary BlackfordDirector0—0Feb 10, 2017 · 4:39 pm ESTForm 4
Carl GoldfischerDirector—00May 31, 2017 · 3:31 pm EDTForm 4/A

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.